Reimbursement

Working with outside peers, individuals within our group have taken part in payment and coverage decisions made by the Centers for Medicare and Medicaid Services (CMS) and private insurers. We have assisted in the development of demonstration projects geared toward improving clinical outcomes, health care access, quality of care, and utilization, while reducing unnecessary costs.

Our understanding of public and private reimbursement policies for new drugs, devices, diagnostics, and episodic care affords a valued perspective on one of the key factors that drives new technology adoption.